CA2007740A1 - Acides quinolinecarboxylique substitue - Google Patents

Acides quinolinecarboxylique substitue

Info

Publication number
CA2007740A1
CA2007740A1 CA2007740A CA2007740A CA2007740A1 CA 2007740 A1 CA2007740 A1 CA 2007740A1 CA 2007740 A CA2007740 A CA 2007740A CA 2007740 A CA2007740 A CA 2007740A CA 2007740 A1 CA2007740 A1 CA 2007740A1
Authority
CA
Canada
Prior art keywords
quinolinecarboxylic acids
substituted
substituted quinolinecarboxylic
disclosed
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2007740A
Other languages
English (en)
Other versions
CA2007740C (fr
Inventor
John Frank Poletto
Dennis William Powell
Diane Harris Boschelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2007740A1 publication Critical patent/CA2007740A1/fr
Application granted granted Critical
Publication of CA2007740C publication Critical patent/CA2007740C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
CA002007740A 1989-01-17 1990-01-15 Acides quinolinecarboxylique substitue Expired - Lifetime CA2007740C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/298,585 1989-01-17
US07/298,585 US4968702A (en) 1989-01-17 1989-01-17 Substituted quinolinecarboxylic acids

Publications (2)

Publication Number Publication Date
CA2007740A1 true CA2007740A1 (fr) 1990-07-17
CA2007740C CA2007740C (fr) 1999-12-07

Family

ID=23151154

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002007740A Expired - Lifetime CA2007740C (fr) 1989-01-17 1990-01-15 Acides quinolinecarboxylique substitue

Country Status (17)

Country Link
US (1) US4968702A (fr)
EP (1) EP0379145B1 (fr)
JP (1) JP3004025B2 (fr)
KR (1) KR0140076B1 (fr)
AT (1) ATE152711T1 (fr)
AU (1) AU624471B2 (fr)
CA (1) CA2007740C (fr)
DE (1) DE69030632T2 (fr)
DK (1) DK0379145T3 (fr)
ES (1) ES2100851T3 (fr)
GR (1) GR3023585T3 (fr)
HK (1) HK1008019A1 (fr)
IE (1) IE900169L (fr)
IL (1) IL92898A (fr)
NZ (1) NZ232111A (fr)
PH (1) PH26961A (fr)
ZA (1) ZA90299B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1999038846A1 (fr) * 1998-01-30 1999-08-05 Procept, Inc. Agents immunosuppresseurs
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
MXPA05001642A (es) * 2002-08-13 2005-04-25 Warner Lambert Co Derivados de naftaleno como inhibidores de metaloproteinasas de matriz.
US7138412B2 (en) * 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
CA2898615A1 (fr) * 2013-01-28 2014-07-31 Viamet Pharmaceuticals, Inc. Composes inhibiteurs de metalloenzyme
KR20160079123A (ko) 2013-11-22 2016-07-05 젠자임 코포레이션 신경변성 질병을 치료하기 위한 신규한 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287804C (fr) *
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds
FR2166297A1 (en) * 1972-01-07 1973-08-17 Rosenberg Eli 2-(4-isopropylphenyl)quinoline-4-carboxylic acid - as a non-toxic, analgesic agent
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0133244B1 (fr) * 1983-07-22 1990-12-05 E.I. Du Pont De Nemours And Company Acides phénylquinolinecarboxyliques et dérivés comme agents antitumoraux
EP0318093A3 (fr) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Acides dicarboxyliques des diaryl quinoléines et leur utilisation comme médicaments

Also Published As

Publication number Publication date
IL92898A0 (en) 1990-09-17
PH26961A (en) 1992-12-28
KR900011733A (ko) 1990-08-02
JP3004025B2 (ja) 2000-01-31
DE69030632D1 (de) 1997-06-12
GR3023585T3 (en) 1997-08-29
HK1008019A1 (en) 1999-04-30
DE69030632T2 (de) 1997-10-02
AU4850290A (en) 1990-07-26
US4968702A (en) 1990-11-06
DK0379145T3 (da) 1997-05-26
KR0140076B1 (ko) 1998-06-01
AU624471B2 (en) 1992-06-11
ATE152711T1 (de) 1997-05-15
EP0379145A3 (fr) 1991-07-17
EP0379145B1 (fr) 1997-05-07
CA2007740C (fr) 1999-12-07
JPH02229166A (ja) 1990-09-11
ES2100851T3 (es) 1997-07-01
IE900169L (en) 1990-07-17
IL92898A (en) 1994-11-28
NZ232111A (en) 1992-07-28
ZA90299B (en) 1990-10-31
EP0379145A2 (fr) 1990-07-25

Similar Documents

Publication Publication Date Title
AU624471B2 (en) Substituted quinolinecarboxylic acids
HU9302330D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
CA2008391A1 (fr) Amides de 2-cyclohexylaminoaryl utilises comme agents analgesiques
HU9302329D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
IE882628L (en) Substituted 2-phenyl-4-quinoline carboxylic acids
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
HUT69063A (en) Process for the preparation of 1,4-disubstituted-5(4h)-tetrazolinones
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
ITMI920794A1 (it) Procedimento per la produzione di carbone attivo
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
IL122708A (en) Process for the production of diastereomerically pure l-azetidine-2-carboxylic acid-d-tartrate or d-azetidine-2-carboxylic acid-l-tartrate
ITMI922551A0 (it) Procedimento per la produzione di carbone attivo
CS675086A2 (en) Zpusob vyroby novych derivatu 1a 13 bromergolinu
IL110425A0 (en) Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines
MA23081A1 (fr) Procede de preparation de derives d'indolone
GB9410256D0 (en) Process for the preparation of co-polymers
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
AU5857190A (en) Process for the treatment of used oil
PT94432A (pt) Processo para a producao sulfonamidas substituidas e compostos afins uteis no tratamento da asma, artrite e doencas afins
FR2702769B1 (fr) Nouveau procede de preparation d'alkylpolyosides faiblement colores.
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202